Want to join the conversation?
OTC consumer goods and pharmaceutical company $PRGO has entered into an exclusive licensing agreement with $FLML for its LiquiTime technology. $PRGO will use the LiquiTime platform to develop a portfolio of extended release suspension products intended for U.S. OTC market. Specific financial terms of the deal were not disclosed.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th